CT-guided percutaneous biopsy of pancreas transplants

Osarugue A. Aideyan, Andrew J. Schmidt, Stephen W. Trenkner, Nadey S. Hakim, Rainer W G Gruessner, James W. Walsh

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

PURPOSE: To evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous needle biopsy in pancreas transplantation patients with graft dysfunction. MATERIALS AND METHODS: Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with 18-gauge needles over a 38-month period. All but one of the transplants were bladder-drained allografts. An average of 2.25 passes (range, 1-4) per allograft were made, and tissue was immediately processed for histopathologic examination. Fifteen patients (19% of biopsy referrals) could not undergo biopsy because a safe approach was not available. RESULTS: Of the 63 biopsy specimens, 57 (90%) were adequate for histopathologic diagnosis, which was normal or no specific abnormality in 14, acute rejection in 20, chronic rejection in one, chronic rejection with cytomegalovirus inclusion bodies in one, acute or chronic pancreatitis in 13, chronic pancreatitis with cytomegalovirus inclusion bodies in one, and miscellaneous in seven. Three specimens contained no pancreatic tissue, and three were insufficient for diagnosis. Minor complications included a transient rise in serum amylase levels in four patients (6%) and transient mild hematuria in one patient (1%). The only major complication (substantial hemorrhage) occurred in two cases (3%). CONCLUSION: CT-guided percutaneous needle biopsy is a safe, alternative method for obtaining tissue in pancreas transplantation patients with graft dysfunction. It may obviate cystoscopic biopsy for bladder-drained grafts or open biopsy in duct-injected or enteric-drained grafts.

Original languageEnglish (US)
Pages (from-to)825-828
Number of pages4
JournalRadiology
Volume201
Issue number3
StatePublished - Dec 1996
Externally publishedYes

Fingerprint

Pancreas
Tomography
Transplants
Biopsy
Pancreas Transplantation
Inclusion Bodies
Chronic Pancreatitis
Needle Biopsy
Cytomegalovirus
Allografts
Urinary Bladder
Hematuria
Amylases
Needles
Referral and Consultation
Hemorrhage
Safety
Serum

Keywords

  • Biopsies, complications
  • Computed tomography (CT)
  • guidance
  • Pancreas, biopsy
  • Pancreas, CT
  • Pancreas, interventional procedure
  • Pancreas, transplantation

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Aideyan, O. A., Schmidt, A. J., Trenkner, S. W., Hakim, N. S., Gruessner, R. W. G., & Walsh, J. W. (1996). CT-guided percutaneous biopsy of pancreas transplants. Radiology, 201(3), 825-828.

CT-guided percutaneous biopsy of pancreas transplants. / Aideyan, Osarugue A.; Schmidt, Andrew J.; Trenkner, Stephen W.; Hakim, Nadey S.; Gruessner, Rainer W G; Walsh, James W.

In: Radiology, Vol. 201, No. 3, 12.1996, p. 825-828.

Research output: Contribution to journalArticle

Aideyan, OA, Schmidt, AJ, Trenkner, SW, Hakim, NS, Gruessner, RWG & Walsh, JW 1996, 'CT-guided percutaneous biopsy of pancreas transplants', Radiology, vol. 201, no. 3, pp. 825-828.
Aideyan OA, Schmidt AJ, Trenkner SW, Hakim NS, Gruessner RWG, Walsh JW. CT-guided percutaneous biopsy of pancreas transplants. Radiology. 1996 Dec;201(3):825-828.
Aideyan, Osarugue A. ; Schmidt, Andrew J. ; Trenkner, Stephen W. ; Hakim, Nadey S. ; Gruessner, Rainer W G ; Walsh, James W. / CT-guided percutaneous biopsy of pancreas transplants. In: Radiology. 1996 ; Vol. 201, No. 3. pp. 825-828.
@article{bf678b3e98c04f93a1708e2cbac5d475,
title = "CT-guided percutaneous biopsy of pancreas transplants",
abstract = "PURPOSE: To evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous needle biopsy in pancreas transplantation patients with graft dysfunction. MATERIALS AND METHODS: Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with 18-gauge needles over a 38-month period. All but one of the transplants were bladder-drained allografts. An average of 2.25 passes (range, 1-4) per allograft were made, and tissue was immediately processed for histopathologic examination. Fifteen patients (19{\%} of biopsy referrals) could not undergo biopsy because a safe approach was not available. RESULTS: Of the 63 biopsy specimens, 57 (90{\%}) were adequate for histopathologic diagnosis, which was normal or no specific abnormality in 14, acute rejection in 20, chronic rejection in one, chronic rejection with cytomegalovirus inclusion bodies in one, acute or chronic pancreatitis in 13, chronic pancreatitis with cytomegalovirus inclusion bodies in one, and miscellaneous in seven. Three specimens contained no pancreatic tissue, and three were insufficient for diagnosis. Minor complications included a transient rise in serum amylase levels in four patients (6{\%}) and transient mild hematuria in one patient (1{\%}). The only major complication (substantial hemorrhage) occurred in two cases (3{\%}). CONCLUSION: CT-guided percutaneous needle biopsy is a safe, alternative method for obtaining tissue in pancreas transplantation patients with graft dysfunction. It may obviate cystoscopic biopsy for bladder-drained grafts or open biopsy in duct-injected or enteric-drained grafts.",
keywords = "Biopsies, complications, Computed tomography (CT), guidance, Pancreas, biopsy, Pancreas, CT, Pancreas, interventional procedure, Pancreas, transplantation",
author = "Aideyan, {Osarugue A.} and Schmidt, {Andrew J.} and Trenkner, {Stephen W.} and Hakim, {Nadey S.} and Gruessner, {Rainer W G} and Walsh, {James W.}",
year = "1996",
month = "12",
language = "English (US)",
volume = "201",
pages = "825--828",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - CT-guided percutaneous biopsy of pancreas transplants

AU - Aideyan, Osarugue A.

AU - Schmidt, Andrew J.

AU - Trenkner, Stephen W.

AU - Hakim, Nadey S.

AU - Gruessner, Rainer W G

AU - Walsh, James W.

PY - 1996/12

Y1 - 1996/12

N2 - PURPOSE: To evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous needle biopsy in pancreas transplantation patients with graft dysfunction. MATERIALS AND METHODS: Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with 18-gauge needles over a 38-month period. All but one of the transplants were bladder-drained allografts. An average of 2.25 passes (range, 1-4) per allograft were made, and tissue was immediately processed for histopathologic examination. Fifteen patients (19% of biopsy referrals) could not undergo biopsy because a safe approach was not available. RESULTS: Of the 63 biopsy specimens, 57 (90%) were adequate for histopathologic diagnosis, which was normal or no specific abnormality in 14, acute rejection in 20, chronic rejection in one, chronic rejection with cytomegalovirus inclusion bodies in one, acute or chronic pancreatitis in 13, chronic pancreatitis with cytomegalovirus inclusion bodies in one, and miscellaneous in seven. Three specimens contained no pancreatic tissue, and three were insufficient for diagnosis. Minor complications included a transient rise in serum amylase levels in four patients (6%) and transient mild hematuria in one patient (1%). The only major complication (substantial hemorrhage) occurred in two cases (3%). CONCLUSION: CT-guided percutaneous needle biopsy is a safe, alternative method for obtaining tissue in pancreas transplantation patients with graft dysfunction. It may obviate cystoscopic biopsy for bladder-drained grafts or open biopsy in duct-injected or enteric-drained grafts.

AB - PURPOSE: To evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous needle biopsy in pancreas transplantation patients with graft dysfunction. MATERIALS AND METHODS: Sixty-three CT-guided core biopsies of 42 pancreas grafts were performed with 18-gauge needles over a 38-month period. All but one of the transplants were bladder-drained allografts. An average of 2.25 passes (range, 1-4) per allograft were made, and tissue was immediately processed for histopathologic examination. Fifteen patients (19% of biopsy referrals) could not undergo biopsy because a safe approach was not available. RESULTS: Of the 63 biopsy specimens, 57 (90%) were adequate for histopathologic diagnosis, which was normal or no specific abnormality in 14, acute rejection in 20, chronic rejection in one, chronic rejection with cytomegalovirus inclusion bodies in one, acute or chronic pancreatitis in 13, chronic pancreatitis with cytomegalovirus inclusion bodies in one, and miscellaneous in seven. Three specimens contained no pancreatic tissue, and three were insufficient for diagnosis. Minor complications included a transient rise in serum amylase levels in four patients (6%) and transient mild hematuria in one patient (1%). The only major complication (substantial hemorrhage) occurred in two cases (3%). CONCLUSION: CT-guided percutaneous needle biopsy is a safe, alternative method for obtaining tissue in pancreas transplantation patients with graft dysfunction. It may obviate cystoscopic biopsy for bladder-drained grafts or open biopsy in duct-injected or enteric-drained grafts.

KW - Biopsies, complications

KW - Computed tomography (CT)

KW - guidance

KW - Pancreas, biopsy

KW - Pancreas, CT

KW - Pancreas, interventional procedure

KW - Pancreas, transplantation

UR - http://www.scopus.com/inward/record.url?scp=0029806320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029806320&partnerID=8YFLogxK

M3 - Article

C2 - 8939238

AN - SCOPUS:0029806320

VL - 201

SP - 825

EP - 828

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -